NEWS & EVENTS
List
Icon
-
Taiwan FDA granted Market License of Bortezomib for Injection 3.5mg "GBC"MORE > -
Tainan Site Cartridge Pen obtained EU GMP (QPD) Compliance Article 13(3)(b) of Directive 2001/20/ECMORE > -
Zhunan Site Dedicated Oncology(Cytotoxic) Aseptic Lyo Injectable Vial Commercial Plant obtained PIC/S GMP Certification by Southeast Asia ClientMORE > -
Zhunan Site Biological Products obtained PMDA AFM Certification.MORE > -
Taiwan FDA granted the API Market License of Azacitidine "GBC"MORE > -
Taiwan FDA granted the API Market License of Bortezomib "GBC"MORE >